Ozurdex FDA Approval History
FDA Approved: Yes (First approved June 17, 2009)
Brand name: Ozurdex
Generic name: dexamethasone
Dosage form: Intravitreal Implant
Company: AbbVie Inc.
Treatment for: Macular Edema, Uveitis
Ozurdex (dexamethasone intravitreal implant) is a sustained-release, corticosteroid implant for the treatment of macular edema, non-infectious uveitis, and diabetic macular edema.
Development timeline for Ozurdex
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.